US 11530236
CD73 inhibitors
granted A61KA61K45/06A61P
Quick answer
US patent 11530236 (CD73 inhibitors) held by ORIC PHARMACEUTICALS, INC. expires Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ORIC PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00